India’s first indigenous vaccine against the H5N1 strain of bird flu in chickens was unveiled in Bhopal on Tuesday. Developed by scientists at the Indian Council of Agricultural Research’s National Institute of High Security Animal Diseases (NIHSAD), the vaccine is priced at Rs 1-2 per dose and is expected to strengthen disease prevention in the poultry sector and reduce economic losses.
Union agriculture and farmers’ welfare and rural development minister Shivraj Singh Chouhan unveiled the vaccine. Describing animal husbandry and poultry as vital pillars of the rural economy, he said livestock function as “moving ATMs” for farmers, providing a regular source of income alongside agriculture. He said animal husbandry contributes 14 per cent to India’s GDP, while the poultry sector accounts for another 1 per cent, and cited average annual losses from livestock diseases.
A NIHSAD scientist said the vaccine is the world’s first against this particular variant of bird flu and is expected to protect the livelihoods of millions of poultry farmers. The research team comprised Dr S Nagarajan, Dr Manoj Kumar, Dr C Tosh, Dr H.V. Murugkar, Dr Aniket Sanyal, Dr Senthil Kumar D., Dr Naveen Kumar and Dr Yogisharadhya R. Scientists worked under stringent biosafety protocols during the research.
India’s first bird flu outbreak was reported in Navapur, Maharashtra, in 2006, killing nearly one million chickens. Since then, the country has witnessed more than 500 outbreaks. Chouhan also announced a new state-of-the-art laboratory in Bhopal at an estimated cost of Rs 300 crore, and said those who question India’s constitutional institutions and scientific capabilities abroad should take note of the country’s achievements.
